エラストマー製輸液ポンプの市場規模、シェア、成長分析、製品別、用途別、最終用途別、地域別 - 産業予測、2024年～2031年

世界のエラストマー製輸液ポンプの市場規模は、2022年に6億3,800万米ドルとなり、2023年の6億8,457万米ドルから、2031年までには12億287万米ドルに成長し、予測期間（2024年～2031年）のCAGRは7.30%で成長する見通しです。

世界のエラストマー製輸液ポンプ市場は、高度な医療送達システムに対するニーズの高まりを強調する要因が重なり、大幅な成長が見込まれています。整形外科的処置や手術の増加、コンパクトで使い捨ての外来用エラストマー製輸液ポンプに対する需要の高まり、急速な技術進歩などが市場拡大に寄与しています。特筆すべきは、慢性疾患、特に糖尿病の蔓延が拡大していることです。国際糖尿病連合による最近の統計は、糖尿病患者の驚くべき増加を示しており、2030年までに約6億4,300万人の成人がこの疾患に罹患すると予測しています。世界保健機関（WHO）によると、このような慢性疾患は年間4,100万人の死因を占めており、効果的な管理ソリューションが緊急に必要であることを強調しています。さらに、米国で年間約5万件の症例が報告されている骨髄炎のような疾患は、特に糖尿病や末梢血管疾患などの合併症を持つ層で増加傾向にあります。このように慢性疾患の負担が急増していることから、安全で効果的な点滴による薬物投与に対する需要が高まっており、エラストマー製輸液ポンプ市場を牽引しています。ヘルスケアシステムが患者の予後改善と革新的技術の採用をますます優先するようになるにつれて、米国のエラストマー製輸液ポンプ市場は今後の予測期間において持続可能なCAGRを達成すると予想されます。この動向は、医療機器業界の利害関係者にとって、患者ケアを強化し、ヘルスケア提供者の進化するニーズに対応する大きな機会を反映しています。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次・一次情報源
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主要な市場の考察

• 技術分析
• バリューチェーン分析
• 市場のエコシステム
• ケーススタディ分析
• 規制情勢
• イノベーションマトリクス
• 主要な投資分析
• 主要な成功要因
• 競合の程度

エラストマー製輸液ポンプ市場：製品別

• 市場概要
• 連続速度エラストマー製輸液ポンプ
• 可変速度エラストマー製輸液ポンプ

エラストマー製輸液ポンプ市場：用途別

• 市場概要
• 疼痛管理
• 化学療法
• 抗生物質 / 抗ウイルス療法
• その他

エラストマー製輸液ポンプ市場：最終用途別

• 市場概要
• 病院
• 外来手術センター
• その他

エラストマー製輸液ポンプ市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主要な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Baxter（US）
• Fresenius Kabi AG（Germany）
• B. Braun SE（Germany）
• Ambu A/S（Denmark）
• NIPRO（Japan）
• Terumo Corporation（Japan）
• AVNS（US）
• Vygon Group（France）
• Smiths Group plc（UK）
• ICU Medical, Inc.（US）
• Pajunk GmbH（Germany）
• Woo Young Medical Co., Ltd.（South Korea）
• Sapphire Medical（Israel）
• Ace Medical Co., Ltd.（South Korea）
• Eitan Medical（Israel）
• Zyno Medical（US）
• Epic Medical（Singapore）
• Nipro Corporation（Japan）
• Daiken Medical Co., Ltd.（Japan）
• Coopdech（Japan）
• Westmed, Inc.（US）
• Flowonix Medical Inc.（US）

Global Elastomeric Infusion Pumps Market size was valued at USD 638 million in 2022 and is poised to grow from USD 684.57 million in 2023 to USD 1202.87 million by 2031, growing at a CAGR of 7.30% during the forecast period (2024-2031).

The global elastomeric infusion pump market is poised for substantial growth, driven by a confluence of factors that highlight the increasing need for advanced medical delivery systems. A rising number of orthopedic procedures and surgeries, heightened demand for compact, disposable ambulatory elastomeric infusion pumps, and rapid technological advancements are all contributing to market expansion. Notably, the growing prevalence of chronic diseases, particularly diabetes, serves as a primary growth catalyst. Recent statistics from the International Diabetes Federation illustrate the alarming rise in diabetes cases, with projections indicating approximately 643 million adults will be affected by the condition by 2030. Such chronic ailments account for 41 million deaths annually, according to the World Health Organization, emphasizing an urgent need for effective management solutions. Additionally, conditions like osteomyelitis, which reports around 50,000 cases annually in the US, are on the rise, notably among demographics with existing comorbidities such as diabetes and peripheral vascular disease. This burgeoning burden of chronic diseases underscores the critical demand for safe and effective medication delivery through intravenous routes, consequently propelling the elastomeric infusion pump market. As healthcare systems increasingly prioritize improved patient outcomes and the adoption of innovative technologies, the US elastomeric infusion pumps market is expected to achieve a sustainable compound annual growth rate (CAGR) in the forecast period ahead. This trend reflects a significant opportunity for stakeholders in the medical device industry to enhance patient care and address the evolving needs of healthcare providers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Elastomeric Infusion Pumps market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Elastomeric Infusion Pumps Market Segmental Analysis

Global Elastomeric Infusion Pumps Market is segmented by Product, Application, End Use, and region. Based on Product, the market is segmented into Continuous Rate Elastomeric Infusion Pumps, and Variable Rate Elastomeric Infusion Pumps. Based on function, the market is segmented into Pain Management, Chemotherapy, Antibiotic/Antiviral Therapy, and Others. Based on End Use, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Elastomeric Infusion Pumps Market

The escalating prevalence of chronic diseases, including diabetes, cancer, and cardiovascular disorders, is a pivotal market driver for the Global Elastomeric Infusion Pumps market. As healthcare systems prioritize efficient and patient-friendly treatment modalities, elastomeric infusion pumps emerge as a preferred choice due to their ability to deliver medications consistently over extended periods. These devices offer several advantages, such as portability, ease of use, and reduced risk of infection, making them ideal for outpatient settings. Consequently, the growing demand for effective long-term medication management solutions significantly boosts the market's growth potential, highlighting the critical role of elastomeric infusion pumps in modern healthcare.

Restraints in the Global Elastomeric Infusion Pumps Market

The Global Elastomeric Infusion Pumps market is significantly restrained by the growing competition from alternative drug delivery systems, particularly electronic infusion pumps and implantable pumps. These alternatives not only incorporate advanced technological features but also provide more precise drug delivery methods, appealing to healthcare providers and patients alike. As these innovative systems continue to evolve, they pose substantial challenges to the adoption and market penetration of elastomeric infusion pumps. This competitive landscape compels manufacturers to enhance the functionality and efficiency of elastomeric devices or risk becoming obsolete, ultimately hindering market growth in the burgeoning healthcare sector.

Market Trends of the Global Elastomeric Infusion Pumps Market

The global elastomeric infusion pumps market is experiencing a significant upward trend, primarily fueled by the increasing demand for home healthcare and ambulatory care solutions. This shift is driven by an aging population seeking cost-effective treatment options, coupled with advancements in medical technology that enhance the usability of these devices. The portability and user-friendly design of elastomeric infusion pumps allow patients to administer continuous medication infusions in the comfort of their own homes, thereby improving patient satisfaction and outcomes. As healthcare facilities face mounting pressures, the rising adoption of these pumps is set to redefine patient care dynamics and reshape market strategies.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Case study Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Elastomeric Infusion Pumps Market by Product

• Market Overview
• Continuous Rate Elastomeric Infusion Pumps
• Variable Rate Elastomeric Infusion Pumps

Elastomeric Infusion Pumps Market by Application

• Market Overview
• Pain Management
• Chemotherapy
• Antibiotic/Antiviral Therapy
• Others

Elastomeric Infusion Pumps Market by End Use

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Others

Elastomeric Infusion Pumps Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Baxter (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ambu A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NIPRO (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AVNS (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vygon Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pajunk GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Woo Young Medical Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sapphire Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ace Medical Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eitan Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zyno Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epic Medical (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daiken Medical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coopdech (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Westmed, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flowonix Medical Inc. (US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments